| Study title |
Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction Therapy in Subjects with Moderately to Severely Active Crohn’s Disease |
| Disease or condition |
Active, moderate to severe Crohn’s disease |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
Etrasimod vs Placebo (open label extension possible) |
| Phase |
2b |
| Study site |
Duke University |
| Study location |
Durham |
| Principal investigator |
Jane Onken |
| Study coordinator |
Christy Walters, christy.walters@duke.edu |
| Phone contact |
919-688-5499 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04173273 |
